Cargando…
Ectokinases as novel cancer markers and drug targets in cancer therapy
While small-molecule kinase inhibitors became the most prominent anticancer drugs, novel combinatorial strategies need to be developed as the fight against cancer is not yet won. We review emerging literature showing that the release of several ectokinases is significantly upregulated in body fluids...
Autores principales: | Yalak, Garif, Vogel, Viola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380966/ https://www.ncbi.nlm.nih.gov/pubmed/25504773 http://dx.doi.org/10.1002/cam4.368 |
Ejemplares similares
-
Proteomic database mining opens up avenues utilizing extracellular protein phosphorylation for novel therapeutic applications
por: Yalak, Garif, et al.
Publicado: (2015) -
Phosphorylated fibronectin enhances cell attachment and upregulates mechanical cell functions
por: Yalak, Garif, et al.
Publicado: (2019) -
Ecto-protein kinases and phosphatases: an emerging field for translational medicine
por: Yalak, Garif, et al.
Publicado: (2014) -
Replication Study: Systematic identification of genomic markers of drug sensitivity in cancer cells
por: Vanden Heuvel, John P, et al.
Publicado: (2018) -
Fascin‐1 as a novel diagnostic marker of triple‐negative breast cancer
por: Wang, Chao‐Qun, et al.
Publicado: (2016)